**Author details**

Shuhang Xu1,2, Guofang Chen1,2, Li Chunrui3 and Chao Liu1,2\*

\*Address all correspondence to: liuchao@nfmcn.com

1 Endocrine and Diabetes Center, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China

2 University of Traditional Chinese Medicine, Jiangsu Branch of China Academy of Chinese Medical Science, Nanjing, China

3 Department of Endocrinology, Weifang Municipal Official Hospital, Weifang, China

## **References**


[8] Anderson JW, Kendall CW, Jenkins DJ. Importance of Weight Management in Type 2 Diabetes: Review with Meta-Analysis of Clinical Studies. Journal of The American College of Nutrition 2003;22(12) 331-339.

**Author details**

192 Treatment of Type 2 Diabetes

**References**

Shuhang Xu1,2, Guofang Chen1,2, Li Chunrui3

Western Medicine, Nanjing, China

Medical Science, Nanjing, China

2007;86(1) 7-13.

2011;32(3) 159-221.

bany NY) 2012;4(8) 525-534.

Medicine 2002;346(6) 393-403.

16-24.

\*Address all correspondence to: liuchao@nfmcn.com

and Chao Liu1,2\*

1 Endocrine and Diabetes Center, Jiangsu Province Hospital on Integration of Chinese and

2 University of Traditional Chinese Medicine, Jiangsu Branch of China Academy of Chinese

[1] Varady KA, Hellerstein MK. Alternate-day Fasting and Chronic Disease Prevention: A Review of Human and Animal Trials. American Journal of Clinical Nutrition

[2] Tucci P. Caloric Restriction: Is Mammalian Life Extension Linked to p53? Aging (Al‐

[3] Speakman JR, Mitchell SE. Caloric Restriction. Molecular Aspects of Medicine

[5] Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitu‐ pa M; Finnish Diabetes Prevention Study Group. Prevention of Type 2 Diabetes Mel‐ litus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New

[6] Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Na‐ than DM; Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal

[7] Kume S, Uzu T, Kashiwagi A, Koya D. SIRT1, a Calorie Restriction Mimetic, in a New Therapeutic Approach for Type 2 Diabetes Mellitus and Diabetic Vascular Complications. Endocrine' Metabolic & Immune Disorders-Drug Targets 2010;10(1)

[4] Fasting and obesity. British Medical Journal 1978;1(6114) 673.

England Journal of Medicine 2011;344(18) 1343-1350.

3 Department of Endocrinology, Weifang Municipal Official Hospital, Weifang, China

